Amyloidosis comprises a heterogeneous group of diseases of diverse etiology characterized by the extracellular deposition of a number of fibrillar proteins which may be distinguished from each other biochemically and immunohistologically. Fibrils are composed of low molecular weight subunits that appear to originate by proteolysis and polymerization of normal serum proteins. In idiopathic and myeloma-associated amyloidoses, subunits derive from circulating monoclonal immunoglobulin light chains and comprise mainly the variable region (1). In secondary amyloidosis, as well as in familial Mediterranean fever, the subunit is the AA protein (2, 3) which is related to a major normal acute-phase reactant, designated SAA (4, 5) . Recent studies have shown that a third form of systemic amyloidosis may occur in association with familial amyloidotic polyneuropathy, a heredofamilial form of amyloidosis (6) that demonstrates autosomal dominant inheritance. Fibril subunit protein with cross-antigenicity to prealbumin has been reported in Portuguese patients affected by this syndrome (7) and limited amino-terminal sequence homology to prealbumin has been shown in two affected American kindreds of Swedish origin (8) . In a previous paper we reported a case of familial amyloidotic polyneuropathy in a Jewish patient ofAshkenazi origin and the partial characterization of the amyloid protein (9) . This paper presents the amino acid sequence ofthree related amyloid proteins derived from tissue of the same. patient, SKO. EXPERIMENTAL PROCEDURES Amyloid fibrils were isolated from thyroid and spleen tissues of patient SKO, as described by Pras et aL (10) . The SKO peaks III, IV, and V ( Fig. 1) were further purified by gel filtration on an Ultrogel AcA 54 (LKB) column equilibrated with 5 M guanidine HCl in 1 M acetic acid.
The purity and molecular weight of each protein fraction were determined in 17% polyacrylamide gels containing 0.1% NaDodSO4 (11 (12) . Completely reduced and alkylated protein SKO was dissolved at 5-10 mg/ml in 70% formic acid, to which was added a 50-fold excess (wt/wt) of cyanogen bromide (Pierce). The reaction was allowed to proceed at room temperature with constant stirring for 72 hr and was stopped by the addition of 10 vol ofdistilled water, followed by lyophilization (13) .
Because the two resultant cyanogen bromide fragments had Mr of 1,600 and 12,400, respectively, they were purified by exhaustive dialysis by using Spectrapor no. 1 membrane tubing, which has a Mr cutoff of 6,000-8,000.
Protein SKO was digested by trypsin treated with N-tosylphenylalanine chloromethyl ketone (Worthington) in 0.2 M NH4HCO3 at pH 8.2 for 1 hr at room temperature at an enzymeto-substrate ratio of 1:100 (wt/wt). Tryptic peptides were isolated by reversed-phase chromatography on a ,uBondapak C18 column (0.78 x 30.0 cm; Waters Associates), with a gradient of 0-66% acetonitrile (Burdick and Jackson, Muskegon, MI) in 0.05% trifluoroacetic acid at pH 2.5. Each peptide was rechromatographed on an alkylphenyl ,uBondapak column (0.38 x 30.0 cm), with a gradient of 0-60% acetonitrile in 0.05 M ammonium acetate at pH 6.5. Digestion by carboxypeptidase A (Sigma) was done in 0.1 M ammonium bicarbonate buffer at pH 8.0 at 37°C for varying time intervals (14) .
Amino acid analyses ofpeptides and proteins were performed with a Durrum D-500 automatic amino acid analyzer (Durrum, Sunnyvale, CA) after hydrolysis in 0.2 ml of 6 M HCl under reduced pressure for 24 hr at 110°C. Forty microliters of a 1% aqueous solution of phenol was added to prevent degradation of tyrosine. Amino-terminal analyses ofpeptides were done by the Edman degradation technique with amino acid analysis to identify the cleaved derivatized amino acid (15, 16) . Automated sequence analyses were performed by using a Beckman 890C sequencer (Beckman) with the Beckman 0.1 M Quadrol program. For small peptides, Polybrene was added to the cup.
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Identification of phenylthiohydantoin amino acids was done by two methods: (i) HPLC with Waters model ALC/GPC-204, equipped with a 0.38 x 30.0 cm ,uBondapak column and eluted with a methanol/water gradient and (ii) automated amino acid analysis with a Durrum D-500 analyzer after hydrolysis in 0.2 ml of6 M HC1 containing 5 dul of5% SnCl2 under reduced pressure for 4 hr at 150'C (17). Cysteine was detected by measuring radioactivity of phenylthiohydantoin [l4C]carboxymethylcysteine in a liquid scintillation counter (Beckman model LS-250).
RESULTS AND DISCUSSION
The gel filtration pattern of amyloid fibrils obtained from the spleen (Fig. 1) yielded five peaks. The void volume, peak I, consisted of heterogeneous mucopolysaccharide material present in all amyloid fibrils (18) . Peak II contained P component, a serum a-globulin that constituted 5-10% of all amyloid deposits (19, 20) , and peaks III, IV, and V were composed of Mr 14,000, 10,000, and 5,000 proteins, respectively. Table 1 shows the amino acid composition of peaks III, IV, and V from the spleen amyloid fibrils compared with human prealbumin and its fragments, residues 1-48 and 49-127. After rechromatography on an Ultrogel AcA 54 column equilibrated in 5 M guanidine HCl in 1 M acetic acid, the purity of peaks III, IV, and V was determined in NaDodSO4/17% polyacrylamide gels (Fig.  1) . The molecular weight, amino acid composition, and partial sequence of peaks III, IV, and V indicated that (i) peak III is the intact prealbumin subunit, (ii) peak V comprises the first 48 residues of the amino terminus, and (iii) peak IV represents residues 49-127 of the carboxyl terminus. to peak III (intact molecule) reacted with the amyloid fibrils, prealbumin, and-normal human sera, antiserum to peak IV only recognized the amyloid fibrils, suggesting that this may be an antibody to a conformational determinant present in amyloid fibrils or a determinant made accessible by the splitting of residues 1-48. Antibodies to prealbumin reacted with peaks III, IV, and V.
The complete amino acid sequence of peaks .III, IV, and V is shown in Fig. 2 , and it was deduced as follows: peak III was submitted to automated Edman degradation which gave the sequence of 18 residues from the amino terminus. Automated Edman degradation ofintact peak V yielded the sequence ofsix residues, which were completely. homologous to the first six amino acids of peak III. Because the only methionine residue of peak III was identified at position 13, the carboxyl-terminal cyanogen bromide fragment of peak III was subjected to automated sequence analysis and gave the sequence to position 53. Amino-terminal sequence analysis of peak IV aligned with residue 49 ofpeak III and extended to residue 82. Four peptides were obtained after trypsin digestion ofpeak IV. The amino acid compositions are shown in Table 2 . Each peptide was subjected to -automated Edman degradation. The sequence ofintact peak (22) . Prealbumin forms a complex with retinol-binding protein, which is a carrier protein for vitamin-A and also is involved -in the transport of thyroxine (23) .
The complete sequence analysis of a protein extracted from amyloid fibrils present in. the Jewish variety of familial amyloidotic polyneuropathy revealed it is homologous to the normal plasma protein, prealbumin. Our studies were facilitated by the extraction of three related-proteins-peak III, the intact molecule, and peaks IV and V, two fragments resulting from enzymatic cleavage between positions 48 and 49 (Lys, Gly). Because there was only one amino acid substitution, glycine for threonine at position 49, it is conceivable that the SKO prealbumin molecule is the expression of a point mutation and the basis for an abnormal metabolism and amyloid fibril formation.
Alternatively, human prealbumin may be genetically polymorphic and the SKO protein represents an isotype or an allele. Although no additional variations from the prototype sequence of human prealbumin were detected, the 10-20% recovery of threonine at position 49 indicates that normal human prealbumin also was present. Thus, a hereditary defect in the normal metabolism ofprealbumin resulting in amyloid fibril formation may be a factor in the disease process of familial amyloidotic polyneuropathy. Because serum from this patient was not available for extensive studies, we cannot answer the questions (i) whether two forms of prealbumin, either as a complex or free, were present in the circulation and (ii) if present, which form was dominant. Immunochemical analysis ofproteins associated with both normals and those with familial amyloidotic polyneuropathy of different ethnic origins will help to answer these questions.
